399441 生物医药
交易中 05-28 14:08:48
资讯
新帖
简况
AI驱动生物医药“效率革命” 科技巨头与资本重金布局
经济参考报 · 05-25
AI驱动生物医药“效率革命” 科技巨头与资本重金布局
5月22日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 05-22
5月22日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
中国宝安：本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业
证券之星 · 05-22
中国宝安：本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业
新股消息 | 天辰生物医药通过港交所聆讯 LP-003冲刺Ⅲ期临床
智通财经 · 05-22
新股消息 | 天辰生物医药通过港交所聆讯 LP-003冲刺Ⅲ期临床
全球并购“向东看”！小摩投行主席：从生物医药到前沿科技，资本正重新审视中国创新价值
智通财经 · 05-21
全球并购“向东看”！小摩投行主席：从生物医药到前沿科技，资本正重新审视中国创新价值
派格生物医药-B(02565)提名廖亦琳为独立非执行董事候选人
智通财经 · 05-19
派格生物医药-B(02565)提名廖亦琳为独立非执行董事候选人
成大生物（688739）披露与控股股东共同设立生物医药产业投资基金进展公告，5月19日股价上涨0.82%
证券之星 · 05-19
成大生物（688739）披露与控股股东共同设立生物医药产业投资基金进展公告，5月19日股价上涨0.82%
中国宝安：本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业
证券之星 · 05-19
中国宝安：本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业
中国宝安：公司核心业务高新科技和生物医药两个板块表现稳健，具备持续造血能力
证券之星 · 05-19
中国宝安：公司核心业务高新科技和生物医药两个板块表现稳健，具备持续造血能力
生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%
金吾财讯 · 05-19
生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%
港股异动 | 派格生物医药-B(02565)尾盘飙升150% 此前与腾瑞制药达成派达康中国大陆独家商业化合作
智通财经 · 05-18
港股异动 | 派格生物医药-B(02565)尾盘飙升150% 此前与腾瑞制药达成派达康中国大陆独家商业化合作
优宁维：公司主要面向高等院校、科研院所、医院和生物医药企业等科研端
证券之星 · 05-15
优宁维：公司主要面向高等院校、科研院所、医院和生物医药企业等科研端
九源基因(02566)更名为“杭州九源基因生物医药股份有限公司”
智通财经 · 05-11
九源基因(02566)更名为“杭州九源基因生物医药股份有限公司”
港股部分生物医药股走强！银诺医药-B涨超42%，三叶草生物-B涨超11%
老虎资讯综合 · 05-11
港股部分生物医药股走强！银诺医药-B涨超42%，三叶草生物-B涨超11%
港股生物医药板块多数走低
第一财经 · 05-11
港股生物医药板块多数走低
中国银行在沪宣布：1万亿元助力生物医药产业发展
上观新闻 · 05-07
中国银行在沪宣布：1万亿元助力生物医药产业发展
第七届上海创新创业青年50人论坛即将举行，项目路演聚焦人工智能、生物医药等五大赛道
蓝鲸财经 · 05-06
第七届上海创新创业青年50人论坛即将举行，项目路演聚焦人工智能、生物医药等五大赛道
港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心
智通财经 · 05-05
港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心
4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 04-23
4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股
两部门：重点推动生物医药研发外包等标准化建设
金吾财讯 · 04-23
两部门：重点推动生物医药研发外包等标准化建设
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":1913.36,"timestamp":1779948528000,"preClose":1943.6,"halted":0,"volume":307854400,"delay":0,"changeRate":-0.0156,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-30.24,"latestTime":"05-28 14:08:48","open":1941.72,"high":1949.56,"low":1896.27,"amount":10520000000,"amplitude":0.0274,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1779951600000},"marketStatusCode":2,"adr":0,"adjPreClose":1943.6,"symbolType":"index","openAndCloseTimeList":[[1779931800000,1779939000000],[1779944400000,1779951600000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441","defaultTab":"news","newsList":[{"id":"2638839588","title":"AI驱动生物医药“效率革命” 科技巨头与资本重金布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2638839588","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638839588?lang=zh_cn&edition=full","pubTime":"2026-05-25 04:33","pubTimestamp":1779654808,"startTime":"0","endTime":"0","summary":"随着人工智能（AI）技术的快速迭代，越来越多科技巨头切入新药研发赛道，AI制药也成为全球产业资本争夺的战略高地。以AI为核心驱动力，新药研发全流程迎来“效率革命”，传统范式被重塑，智能技术正在改写全球药物研发的产业格局。科技巨头与资本重金布局当前，AI制药成为全球产业资本、政策制定者与科研机构共同聚焦的战略高地，相关领域的合作及投融资事件也出现井喷。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605253747546246.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605253747546246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","AAPL","AIPO","ARTY","NVDA","META","161726","399441","AGIX","MSFT","GOOG","BK4588","TSLA","XBI","XMAG","BK4585","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637251394","title":"5月22日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637251394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637251394?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:38","pubTimestamp":1779439093,"startTime":"0","endTime":"0","summary":"证券之星消息，5月22日上海莱士创60日新低，收盘报5.23元，当日跌1.88%，换手率0.49%，成交量32.78万手，成交额1.72亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200030113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002252","BK0196","161726","BK0188","BK0046","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637936394","title":"中国宝安：本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2637936394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637936394?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:24","pubTimestamp":1779438252,"startTime":"0","endTime":"0","summary":"证券之星消息，中国宝安(000009)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在商业航天领域有布局么中国宝安回复：感谢您的关注。本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业，详情可参见公司定期报告。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200029548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1148","BK0196","BK0131","BK0037","161726","BK0188","BK0139","BK0265","09979","399441","BK0076","000009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637500613","title":"新股消息 | 天辰生物医药通过港交所聆讯 LP-003冲刺Ⅲ期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2637500613","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637500613?lang=zh_cn&edition=full","pubTime":"2026-05-22 06:38","pubTimestamp":1779403082,"startTime":"0","endTime":"0","summary":"于最后实际可行日期，天辰生物医药已在中国启动八项关于LP-003的临床试验，其中两项已完成，其余六项仍在进行中。目前，正在中国进行LP-003用于季节性AR适应症的III期临床试验，并计划在2026年第三季度或之前向国家药监局提交BLA。公司正在开展过敏性哮喘及CRSwNP的II期临床试验，并预计于2026年第四季度启动其他过敏性疾病的II期临床试验。于最后实际可行日期，天辰生物医药于短期内并无计划就LP-003订立任何合作或对外授权安排。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","BK4581","399441","HEXmain","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637800983","title":"全球并购“向东看”！小摩投行主席：从生物医药到前沿科技，资本正重新审视中国创新价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2637800983","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637800983?lang=zh_cn&edition=full","pubTime":"2026-05-21 19:12","pubTimestamp":1779361957,"startTime":"0","endTime":"0","summary":"她进一步补充道：“中国在生物医药、前沿科技领域的创新成果层出不穷，外界对中国的认知正迎来全新转变，这一发展趋势十分良性。”随着大批药品专利即将到期，全球制药企业争相引进中国研发的试验性新药授权，以此压缩研发生产成本。政治因素重塑交易版图在特朗普访华期间，中美双方同意设立投资委员会，旨在促进非敏感领域跨境资本流动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2746668461.USD","LU0006306889.USD","XBI","IE00B1XK9C88.USD","LU0345769631.USD","IE00BLSP4239.USD","LU1629891620.HKD","LU0256863811.USD","LU0496365809.HKD","BK4585","LU0265550359.USD","LU0106831901.USD","IE00BHPRN162.USD","LU2552382058.USD","LU2592432038.USD","IE00BWXC8680.SGD","LU0211327993.USD","LU1496350502.SGD","LU2505996509.AUD","LU2462157665.USD","SG9999002224.SGD","LU2430703095.HKD","399441","LU1894683264.USD","LU0882574139.USD","BK4566","LU1267930490.SGD","LU1894683348.USD","JPX","LU2211815571.USD","LU2746668974.SGD","LU2552382215.SGD","LU1244550221.USD","LU1917777945.USD","LU2023250843.SGD","161726","LU1551013425.SGD","BK4550","LU0106261372.USD","LU2213496289.HKD","BK4534","LU0211326755.USD","LU0640476718.USD","JPMO","JPO","LU0211326839.USD","LU1670627923.USD","BK4504","LU2430703178.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855893","title":"派格生物医药-B(02565)提名廖亦琳为独立非执行董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855893","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636855893?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:44","pubTimestamp":1779191040,"startTime":"0","endTime":"0","summary":"于2026年5月19日，董事会已审议并批准相关决议案，提名廖亦琳女士为公司第二届董事会独立非执行董事候选人。廖亦琳女士的任期将自公司股东大会批准当日起至第二届董事会任期届满时止。待廖亦琳女士于股东大会上获选为独立非执行董事后，廖亦琳女士将接替范新鹏女士担任审计委员会主席以及薪酬与考核委员会及提名委员会各自的成员，任期与其担任第二届董事会独立非执行董事的任期一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","XBI","161726","BK1161","399441","BK4585","BK4581","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636837169","title":"成大生物（688739）披露与控股股东共同设立生物医药产业投资基金进展公告，5月19日股价上涨0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636837169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636837169?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:10","pubTimestamp":1779185437,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，成大生物报收于23.23元，较前一交易日上涨0.82%，最新总市值为96.74亿元。该股当日开盘22.93元，最高23.27元，最低22.93元，成交额达2727.51万元，换手率为0.28%。辽宁成大生物股份有限公司于近日披露《关于与控股股东及其全资子公司共同对外投资暨关联交易事项的进展公告》。公告显示，公司与控股股东辽宁成大及其全资子公司成大沿海、深圳成大生物共同投资设立成大（大连）生物医药产业投资基金合伙企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","688739","BK0239","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636835233","title":"中国宝安：本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2636835233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636835233?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:54","pubTimestamp":1779177247,"startTime":"0","endTime":"0","summary":"证券之星消息，中国宝安(000009)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在锂矿、算力、液冷、数据中心、光模块有布局么中国宝安回复：感谢您的关注。本公司从事的主要业务涉及高新技术产业、生物医药产业、房地产及其他产业，详情可参见公司定期报告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900025298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0265","399441","161726","BK0131","BK1148","BK0196","BK0037","BK0188","000009","09979","BK0139","BK0076"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636783552","title":"中国宝安：公司核心业务高新科技和生物医药两个板块表现稳健，具备持续造血能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2636783552","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636783552?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:39","pubTimestamp":1779176345,"startTime":"0","endTime":"0","summary":"证券之星消息，中国宝安05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司2025年归母净利润2.03亿，扣非后亏损7159万，主业盈利质量堪忧。公司2025年度扣非净利润由正转负以及财务费用同比增加，主要系本年汇兑损失增加影响；公司核心业务高新科技和生物医药两个板块表现稳健，具备持续造血能力；公司利息支出及有息债务整体规模未出现大幅上涨，债务风险整体可控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900022866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0265","BK0131","399441","BK0037","161726","BK0196","000009","BK0188","BK0076"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636885146?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","BK1576","LU0823426308.USD","02268","LU1242518931.SGD","06990","SG9999014674.SGD","LU0708995583.HKD","LU0052750758.USD","LU0348825331.USD","06160","LU0417516902.SGD","BK1574","LU0307460666.USD","XBI","ONC","LU1251922891.USD","01548","LU0181495838.USD","LU3063872942.SGD","02269","BK1161","IE00B0JY6N72.USD","LU1303224171.USD","09969","688235","BK1583","BK4588","LU0417516738.SGD","LU0516422366.SGD","161726","LU0516422440.USD","LU0359202008.SGD","BK1588","HK0000306701.USD","LU0359201612.USD","LU1770034418.SGD","HK0000320264.USD","BK1589","LU1688375341.USD","LU0588546209.SGD","LU1719994722.HKD","BK4581","BK1141","LU0043850808.USD","LU0039217434.USD","LU0456846285.SGD","399441","SG9999002562.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636302846","title":"港股异动 | 派格生物医药-B(02565)尾盘飙升150% 此前与腾瑞制药达成派达康中国大陆独家商业化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2636302846","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636302846?lang=zh_cn&edition=full","pubTime":"2026-05-18 15:43","pubTimestamp":1779090229,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物医药-B(02565)尾盘飙升150%，截至发稿，涨106.97%，报23.16港元，成交额7.84亿港元。消息面上，派格生物医药今年3月公布，与腾瑞制药就派达康在中国大陆地区的商业化合作签署战略合作协议。双方在合作协议中确立以实现累计销售规模超过人民币100亿元作为核心商业化目标。根据合作协议，腾瑞制药将向公司支付合计约1.4亿港币的权益金。值得注意的是，5月12日，方舟健客与腾瑞制药举行战略合作签约仪式。本次战略签约后，备受瞩目的创新GLP-1类药物派达康（维培那肽注射液）将于近期在方舟健客互联网医院平台全网首发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1191","BK1161","01477","399441","BK4588","02565","161726","BK1574","XBI","VXUS","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635277918","title":"优宁维：公司主要面向高等院校、科研院所、医院和生物医药企业等科研端","url":"https://stock-news.laohu8.com/highlight/detail?id=2635277918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635277918?lang=zh_cn&edition=full","pubTime":"2026-05-15 11:33","pubTimestamp":1778816000,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：冷总，公司在防病毒领域有没有设计相关产品？优宁维回复：投资者您好，公司主要面向高等院校、科研院所、医院和生物医药企业等科研端，提供生命科学试剂、设备、耗材、综合技术服务等产品和服务，产品覆盖基因、蛋白、细胞、组织及动物等不同水平的研究对象，助力生命科学的发展和创新。谢谢以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500018570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","161726","301166","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634829282","title":"九源基因(02566)更名为“杭州九源基因生物医药股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2634829282","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634829282?lang=zh_cn&edition=full","pubTime":"2026-05-11 21:19","pubTimestamp":1778505581,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因 发布公告，公司已于2025年4月17日取得香港公司注册处处长签发的注册非香港公司变更名称注册证明书，确认根据公司条例第16部在香港注册的公司英文名称已由“Hangzhou Jiuyuan Gene Engineering Co., Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.”，而中文名称已由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”。更改公司名称后，公司的股份代号、中文股票简称及英文股票简称保持不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","161726","XBI","BK4585","BK4588","BK4581","BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188980056","title":"港股部分生物医药股走强！银诺医药-B涨超42%，三叶草生物-B涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188980056","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188980056?lang=zh_cn&edition=full","pubTime":"2026-05-11 13:25","pubTimestamp":1778477154,"startTime":"0","endTime":"0","summary":"5月11日，港股部分生物医药股走强，$银诺医药-B(02591)$涨超42%，$三叶草生物-B(02197)$涨超11%，$君实生物(01877)$涨超8%，$来凯医药-B(02105)$涨超7%，$荃信生物-B(02509)$涨近5%，$药明巨诺-B(02126)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"68e9cc22a457e84dfc55ae6520639fb8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","VXUS","BK4588","399441","XBI","BK4581","02197","02591","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634473684","title":"港股生物医药板块多数走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2634473684","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634473684?lang=zh_cn&edition=full","pubTime":"2026-05-11 09:58","pubTimestamp":1778464732,"startTime":"0","endTime":"0","summary":"港股生物医药板块多数走低","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113732760661.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113732760661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","VXUS","XBI","399441","161726","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633140242","title":"中国银行在沪宣布：1万亿元助力生物医药产业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2633140242","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633140242?lang=zh_cn&edition=full","pubTime":"2026-05-07 21:00","pubTimestamp":1778158846,"startTime":"0","endTime":"0","summary":"生物医药产业迎来一场及时雨。5月7日，中国银行在上海发布《支持生物医药全链条创新发展行动方案》，将在“十五五”期间，为生物医药全产业链提供不少于1万亿元综合金融支持，以金融活水助力这一新兴产业迈向新高度。中国银行在上海发布《支持生物医药全链条创新发展行动方案》根据方案，中国银行将聚焦长三角、京津冀、大湾区、成渝等核心集聚区，助力构建政策引导、科技推动、金融赋能的产业生态体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073730398873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["601988","LU1224444064.USD","LU1634259557.SGD","BK0278","BK0028","LU2097828557.USD","BK4588","LU1634259391.SGD","BK1521","BK0012","BK0183","03988","LU1522347837.USD","LU2097828714.EUR","XBI","BK0188","LU1497733631.SGD","LU0348805143.USD","IE00BQJZWZ67.USD","SG9999001093.SGD","LU1282651121.HKD","LU0651947912.USD","LU2097828805.USD","399441","LU1051769294.HKD","BK4585","LU1497734951.SGD","SG9999006597.SGD","LU0293314216.USD","BK1231","IE00BWDBJ730.SGD","LU1497733557.USD","161726","LU0072462343.USD","BK4581","LU0588546209.SGD","LU2097828474.EUR","03143","HK0000286598.CNH","LU1515016050.SGD","LU2097828631.EUR","BK0015","LU0307460666.USD","LU1282651048.USD","BK1560","LU1048588211.SGD","IE00B19Z5X02.USD","LU0651946864.USD","LU1051768304.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181277","title":"第七届上海创新创业青年50人论坛即将举行，项目路演聚焦人工智能、生物医药等五大赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181277","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633181277?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:46","pubTimestamp":1778064383,"startTime":"0","endTime":"0","summary":"图片来源：视觉中国蓝鲸新闻5月6日讯记者获悉，第七届上海创新创业青年50人论坛将于2026年5月10日在上海中心举行，以“青年与城市共成长”为主题，包含主论坛与青年科创嘉年华两大活动板块。上海高校创新创业共同体作为本届论坛重磅发布的长效机制平台，将在青年科创嘉年华上海交通大学分会场正式启动。同时，论坛将推出2026上海青年创新创业研修营，并发布上海青年创新创业政策服务包。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1778064184167321209","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["161726","161022","161631","399441","BK4581","ARTY","BK4585","XBI","AGIX","CHAT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633990288","title":"港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2633990288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633990288?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:03","pubTimestamp":1777968239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物医药-B今日走势强劲，盘中最高涨18.91%，报29.3港元，成交额达5965.98万港元。消息面上，派格生物医药近期公布，基石投资者同意自愿禁售期届满日起至5月20日不会以任何方式减持任何持股。公司认为，禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","BK1161","BK4581","399441","XBI","VXUS","BK4585","BK4588","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629886570","title":"4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629886570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629886570?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:24","pubTimestamp":1776932643,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日甘李药业跌9.44%，收盘报59.48元，换手率3.86%，成交量21.51万手，成交额13.09亿元。重仓甘李药业的前十大公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共42家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.1亿元，最新净值0.398，较上一交易日上涨0.45%，近一年上涨13.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300044541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","399441","BK0239","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629064450","title":"两部门：重点推动生物医药研发外包等标准化建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2629064450","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629064450?lang=zh_cn&edition=full","pubTime":"2026-04-23 12:26","pubTimestamp":1776918412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 商务部、市场监管总局印发《服务贸易标准化工作行动计划（2026—2030年）》。其中提到，加大知识产权、科技服务、地理信息、人力资源、语言、咨询、检验检测、创意设计服务等领域的标准研制力度，推动相关标准覆盖行业境内外服务提供的全链条，提升专业服务机构的国际化服务能力。提升服务外包标准化水平，重点推动生物医药研发外包、与制造业融合发展信息技术外包、服务外包企业知识产权保护等方面的标准化建设。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979745","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK4588","399441","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779948530921,"stockEarnings":[{"period":"1week","weight":-0.0371},{"period":"1month","weight":-0.0872},{"period":"3month","weight":-0.1084},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0279},{"period":"ytd","weight":-0.0943}],"compareEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0128},{"period":"6month","weight":0.0528},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0315}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}